Company: NOTV
Filing Date: 2025-02-06
Form Type: 10-Q
Source: 0001628280-25-004178
Chunk: 14

Company: Inotiv, Inc.
Filing Date: 2025-02-06
Form: 10-Q
Item: Part I, Item 1
Chunk 14
---
 amortization: DSA$4,583 $4,409 RMS9,438 9,737   Unallocated Corporate158 104  $14,179 $14,250  Capital expenditures:DSA$376 2,275 RMS4,083 3,297  $4,459 $5,572 Geographic InformationThe following represents revenue originating in entities physically located in the identified geographic area:Three Months EndedDecember 31,20242023United States$97,399 $111,769 Netherlands15,834 18,062 Other6,643 5,670 $119,876 $135,501 Long-lived assets shown below include property and equipment, net. The following represents long-lived assets where they are physically located:December 31,September 30,20242024United States$163,221 $167,772 Netherlands6,278 7,159 Other12,780 13,397 $182,279 $188,328 

15

4.    DEBT

Long-term debt as of December 31, 2024 and September 30, 2024 is detailed in the table below. December 31, 2024September 30, 2024Seller Note – Bolder BioPath (Related party)$320 $376 Seller Note – Preclinical Research Services— 464 Seller Payable - Orient BioResource Center3,235 3,700 Seller Note – Histion (Related party)48 84 Second Lien Notes19,221 17,846 Convertible Senior Notes111,551 109,979 Term Loan Facility, DDTL and Incremental Term Loans272,327 272,840 Total debt before unamortized debt issuance costs$406,702 $405,289 Less: Debt issuance costs not amortized(10,687)(11,950)Total debt, net of unamortized debt issuance costs$396,015 $393,339 Less: Current portion(3,037)(3,538)Total Long-term debt$392,978 $389,801 Revolving Credit FacilityAs of December 31, 2024 and September 30, 2024, the Company had no outstanding balance on the revolving credit facility. Refer to the statements of cash flows for information related to borrowings and payments on the revolving credit